<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38500884</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Determinants of immunoglobulin G responses to respiratory syncytial virus and rhinovirus in children and adults.</ArticleTitle><Pagination><StartPage>1355214</StartPage><MedlinePgn>1355214</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1355214</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1355214</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Exposure to respiratory viruses is a significant cause of morbidity and affects virus-specific antibody levels. Little is known about determinants associated with immune response to these viruses. We aimed to investigate the determinants of respiratory syncytial virus (RSV)- and rhinovirus (RV)- specific IgG responses in both children and adults.</AbstractText><AbstractText Label="METHODS">The study is based on the EGEA cohort, composed of 530 samples of children in EGEA1 (1991-95) and 1241 samples of adults in EGEA2 (2003-07). Cumulative RV-specific IgG levels (species A, B and C) and IgG levels to RSV-G protein were measured by using micro-array technoloy. Multiple linear mixed models (random effect to account for familial dependence) were performed to assess associations between age, sex, body mass index (BMI), tobacco smoke exposure and season of blood sampling with RSV-and RV-specific IgG levels.</AbstractText><AbstractText Label="RESULTS">In children (11.1 ± 2.8 years old, 57% boys), higher RV-specific IgG levels were associated with older age (only for RV-B), female sex and lower BMI, while only older age was associated with higher RSV-specific IgG levels. In adults (43.5 ± 16.7 years old, 48% men), younger age, female sex, lower BMI, active smoking and all seasons except summer were associated with higher RV-specific IgG levels. Older age, active smoking and all seasons except summer were associated with higher RSV-specific IgG levels.</AbstractText><AbstractText Label="CONCLUSION">Personal and seasonal determinants of RSV- and RV-specific IgG levels seem to vary according to the respiratory virus type and between children and adults, suggesting different patterns of responses along the life course.</AbstractText><CopyrightInformation>Copyright © 2024 Guillien, Niespodziana, Mauclin, Boudier, Varraso, Leynaert, Dumas, Le Moual, Schlederer, Bajic, Borochova, Errhalt, Vernet, Nadif, Bousquet, Bouzigon, Valenta and Siroux.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guillien</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Team in Environmental Epidemiology Applied to Development and Respiratory Health, Institute for Advanced Biosciences, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niespodziana</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauclin</LastName><ForeName>Marion</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Team in Environmental Epidemiology Applied to Development and Respiratory Health, Institute for Advanced Biosciences, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boudier</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Team in Environmental Epidemiology Applied to Development and Respiratory Health, Institute for Advanced Biosciences, Grenoble, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU Grenoble Alpes, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varraso</LastName><ForeName>Raphäelle</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, Centre de recherche en Epidémiologie et Santé des Populations (CESP), Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leynaert</LastName><ForeName>Bénédicte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, Centre de recherche en Epidémiologie et Santé des Populations (CESP), Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumas</LastName><ForeName>Orianne</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, Centre de recherche en Epidémiologie et Santé des Populations (CESP), Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Moual</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, Centre de recherche en Epidémiologie et Santé des Populations (CESP), Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlederer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bajic</LastName><ForeName>Maja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Karl Landsteiner University, Krems, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borochova</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Errhalt</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Karl Landsteiner University, Krems, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pneumology, University Hospital, Krems, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernet</LastName><ForeName>Raphaël</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Université Paris Cité, Inserm, UMRS 1124, Group of Genomic Epidemiology of Multifactorial Diseases, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadif</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, Centre de recherche en Epidémiologie et Santé des Populations (CESP), Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bousquet</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Université Paris-Saclay, UVSQ, Université Paris-Sud, Inserm, Equipe d'Epidémiologie Respiratoire Intégrative, Centre de recherche en Epidémiologie et Santé des Populations (CESP), Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouzigon</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Université Paris Cité, Inserm, UMRS 1124, Group of Genomic Epidemiology of Multifactorial Diseases, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valenta</LastName><ForeName>Rudolf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Karl Landsteiner University, Krems, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siroux</LastName><ForeName>Valérie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Team in Environmental Epidemiology Applied to Development and Respiratory Health, Institute for Advanced Biosciences, Grenoble, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="Y">Respiratory Syncytial Virus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adults</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">immunoglobulin G</Keyword><Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword></KeywordList><CoiStatement>Author RuV has received research grants from Worg Pharmaceuticals, Hangzhou, China, HVD Biotech, Vienna, Austria; and Viravaxx, Vienna, Austria. He serves as a consultant for Viravaxx and Worg. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>19</Day><Hour>3</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38500884</ArticleId><ArticleId IdType="pmc">PMC10945029</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1355214</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, et al. . Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. (2018) 18:1191–210. doi: 10.1016/S1473-3099(18)30310-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30310-4</ArticleId><ArticleId IdType="pmc">PMC6202443</ArticleId><ArticleId IdType="pubmed">30243584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansel TT, Johnston SL, Openshaw PJ. Microbes and mucosal immune responses in asthma. Lancet. (2013) 381:861–73. doi: 10.1016/S0140-6736(12)62202-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)62202-8</ArticleId><ArticleId IdType="pubmed">23428115</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll KN, Wu P, Gebretsadik T, Griffin MR, Dupont WD, Mitchel EF, et al. . The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol. (2009) 123:1055–1061.e1. doi: 10.1016/j.jaci.2009.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2009.02.021</ArticleId><ArticleId IdType="pmc">PMC2703291</ArticleId><ArticleId IdType="pubmed">19361850</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman AS, He Y, Moore ML, Hershenson MB, Hartert TV. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. Am J Respir Crit Care Med. (2015) 191:34–44. doi: 10.1164/rccm.201405-0901PP</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201405-0901PP</ArticleId><ArticleId IdType="pmc">PMC4299628</ArticleId><ArticleId IdType="pubmed">25369458</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubner FJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Pappas TE, et al. . Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol. (2017) 139:501–7. doi: 10.1016/j.jaci.2016.03.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.03.049</ArticleId><ArticleId IdType="pmc">PMC5104680</ArticleId><ArticleId IdType="pubmed">27312820</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol. (2017) 140:895–906. doi: 10.1016/j.jaci.2017.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.08.003</ArticleId><ArticleId IdType="pmc">PMC7172811</ArticleId><ArticleId IdType="pubmed">28987219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiogi M, Dumas O, Hasegawa K, Jartti T, Camargo CA. Identifying and predicting severe bronchiolitis profiles at high risk for developing asthma: Analysis of three prospective cohorts. eClinicalMedicine. (2022) 43:101257. doi: 10.1016/j.eclinm.2021.101257</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101257</ArticleId><ArticleId IdType="pmc">PMC8741473</ArticleId><ArticleId IdType="pubmed">35028545</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosas-Salazar C, Chirkova T, Gebretsadik T, Chappell JD, Peebles RS, Dupont WD, et al. . Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study. Lancet. (2023) 401:1669–80. doi: 10.1016/S0140-6736(23)00811-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00811-5</ArticleId><ArticleId IdType="pmc">PMC10367596</ArticleId><ArticleId IdType="pubmed">37086744</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymann PW, Kennedy JL. Rhinovirus-induced asthma exacerbations during childhood: The importance of understanding the atopic status of the host. J Allergy Clin Immunol. (2012) 130:1315–6. doi: 10.1016/j.jaci.2012.10.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2012.10.024</ArticleId><ArticleId IdType="pmc">PMC4379703</ArticleId><ArticleId IdType="pubmed">23195527</ArticleId></ArticleIdList></Reference><Reference><Citation>von Linstow ML, Høgh M, Nordbø SA, Eugen-Olsen J, Koch A, Høgh B. A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life. Eur J Pediatr. (2008) 167:1125–33. doi: 10.1007/s00431-007-0643-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-007-0643-4</ArticleId><ArticleId IdType="pmc">PMC7086915</ArticleId><ArticleId IdType="pubmed">18172683</ArticleId></ArticleIdList></Reference><Reference><Citation>Omenaas E, Bakke P, Haukenes Q, Hanoa R, Gulsvik A. Respiratory virus antibodies in adults of a norwegian community: prevalences and risk factors. Int J Epidemiol. (1995) 24:223–31. doi: 10.1093/ije/24.1.223</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/24.1.223</ArticleId><ArticleId IdType="pubmed">7797347</ArticleId></ArticleIdList></Reference><Reference><Citation>Crothers K, Daly KR, Rimland D, Goetz MB, Gibert CL, Butt AA, et al. . Decreased serum antibody responses to recombinant Pneumocystis antigens in HIV-infected and uninfected current smokers. Clin Vaccine Immunol. (2011) 18:380–6. doi: 10.1128/CVI.00421-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00421-10</ArticleId><ArticleId IdType="pmc">PMC3067379</ArticleId><ArticleId IdType="pubmed">21191078</ArticleId></ArticleIdList></Reference><Reference><Citation>Niespodziana K, Stenberg-Hammar K, Megremis S, Cabauatan CR, Napora-Wijata K, Vacal PC, et al. . PreDicta chip-based high resolution diagnosis of rhinovirus-induced wheeze. Nat Commun. (2018) 9:2382. doi: 10.1038/s41467-018-04591-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04591-0</ArticleId><ArticleId IdType="pmc">PMC6006174</ArticleId><ArticleId IdType="pubmed">29915220</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallard E, Niespodziana K, Bajic M, Schlederer T, Errhalt P, Behrendt AK, et al. . Microarray-based analyses of rhinovirus species-specific antibody responses in exacerbated pediatric asthma in a German pediatric cohort. Viruses. (2022) 14:1857. doi: 10.3390/v14091857</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14091857</ArticleId><ArticleId IdType="pmc">PMC9502376</ArticleId><ArticleId IdType="pubmed">36146664</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi T, Devries M, Bacharier LB, Busse W, Camargo CA, Cohen R, et al. . Enhanced neutralizing antibody responses to rhinovirus C and age-dependent patterns of infection. Am J Respir Crit Care Med. (2021) 203:822–30. doi: 10.1164/rccm.202010-3753OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202010-3753OC</ArticleId><ArticleId IdType="pmc">PMC8017585</ArticleId><ArticleId IdType="pubmed">33357024</ArticleId></ArticleIdList></Reference><Reference><Citation>Esquivel A, Busse WW, Calatroni A, Togias AG, Grindle KG, Bochkov YA, et al. . Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma. Am J Respir Crit Care Med. (2017) 196:985–92. doi: 10.1164/rccm.201701-0120OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201701-0120OC</ArticleId><ArticleId IdType="pmc">PMC5649984</ArticleId><ArticleId IdType="pubmed">28608756</ArticleId></ArticleIdList></Reference><Reference><Citation>Niespodziana K, Napora K, Cabauatan C, Focke-Tejkl M, Keller W, Niederberger V, et al. . Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections. FASEB J. (2012) 26:1001–8. doi: 10.1096/fj.11-193557</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.11-193557</ArticleId><ArticleId IdType="pubmed">22121050</ArticleId></ArticleIdList></Reference><Reference><Citation>Borochova K, Niespodziana K, Stenberg Hammar K, Van Hage M, Hedlin G, Söderhäll C, et al. . Features of the human antibody response against the respiratory syncytial virus surface glycoprotein G. Vaccines. (2020) 8:337. doi: 10.3390/vaccines8020337</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines8020337</ArticleId><ArticleId IdType="pmc">PMC7350215</ArticleId><ArticleId IdType="pubmed">32630611</ArticleId></ArticleIdList></Reference><Reference><Citation>Niespodziana K, Stenberg-Hammar K, Papadopoulos NG, Focke-Tejkl M, Errhalt P, Konradsen JR, et al. . Microarray technology may reveal the contribution of allergen exposure and rhinovirus infections as possible triggers for acute wheezing attacks in preschool children. Viruses. (2021) 13:915. doi: 10.3390/v13050915</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13050915</ArticleId><ArticleId IdType="pmc">PMC8155838</ArticleId><ArticleId IdType="pubmed">34063445</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauffmann F, Dizier MH. EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)–design issues. EGEA Co-operative Group Clin Exp Allergy. (1995) 25 Suppl 2:19–22. doi: 10.1111/j.1365-2222.1995.tb00413.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.1995.tb00413.x</ArticleId><ArticleId IdType="pubmed">8590334</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng S, Guo L, Cohen C, Meijer A, Moyes J, Pasittungkul S, et al. . Impact of subgroup distribution on seasonality of human respiratory syncytial virus: A global systematic analysis. J Infect Dis. (2023), jiad192. doi: 10.1093/infdis/jiad192</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad192</ArticleId><ArticleId IdType="pubmed">37249267</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of respiratory viral infections. Annu Rev Virol. (2020) 7:83–101. doi: 10.1146/annurev-virology-012420-022445</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-012420-022445</ArticleId><ArticleId IdType="pubmed">32196426</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson RA, Cavanaugh JE. Ordered quantile normalization: a semiparametric transformation built for the cross-validation era. J Appl Stat. (2020) 47:2312–27. doi: 10.1080/02664763.2019.1630372</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02664763.2019.1630372</ArticleId><ArticleId IdType="pmc">PMC9042069</ArticleId><ArticleId IdType="pubmed">35707424</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenberg-Hammar K, Niespodziana K, Söderhäll C, James A, Cabauatan CR, Konradsen JR, et al. . Rhinovirus-specific antibody responses in preschool children with acute wheeze reflect severity of respiratory symptoms. Allergy. (2016) 71:1728–35. doi: 10.1111/all.12991</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.12991</ArticleId><ArticleId IdType="pubmed">27444786</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. (2016) 16:626–38. doi: 10.1038/nri.2016.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen H, Klein SL. Sex differences in immunity to viral infections. Front Immunol. (2021) 12:720952. doi: 10.3389/fimmu.2021.720952</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.720952</ArticleId><ArticleId IdType="pmc">PMC8438138</ArticleId><ArticleId IdType="pubmed">34531867</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneja V. Sex hormones determine immune response. Front Immunol. (2018) 9:1931. doi: 10.3389/fimmu.2018.01931</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01931</ArticleId><ArticleId IdType="pmc">PMC6119719</ArticleId><ArticleId IdType="pubmed">30210492</ArticleId></ArticleIdList></Reference><Reference><Citation>De Heredia FP, Gómez-Martínez S, Marcos A. Obesity, inflammation and the immune system. Proc Nutr Soc. (2012) 71:332–8. doi: 10.1017/S0029665112000092</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0029665112000092</ArticleId><ArticleId IdType="pubmed">22429824</ArticleId></ArticleIdList></Reference><Reference><Citation>Hameed M, Geerling E, Pinto AK, Miraj I, Weger-Lucarelli J. Immune response to arbovirus infection in obesity. Front Immunol. (2022) 13:968582. doi: 10.3389/fimmu.2022.968582</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.968582</ArticleId><ArticleId IdType="pmc">PMC9716109</ArticleId><ArticleId IdType="pubmed">36466818</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Henao-Mejia J, Henrickson SE. Obesity and immune status in children. Curr Opin Pediatr. (2020) 32:805–15. doi: 10.1097/MOP.0000000000000953</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000000953</ArticleId><ArticleId IdType="pmc">PMC8489265</ArticleId><ArticleId IdType="pubmed">33105275</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla SD, Mahmood MQ, Weston S, Latham R, Muller HK, Sohal SS, et al. . The main rhinovirus respiratory tract adhesion site (ICAM-1) is upregulated in smokers and patients with chronic airflow limitation (CAL). Respir Res. (2017) 18:6. doi: 10.1186/s12931-016-0483-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-016-0483-8</ArticleId><ArticleId IdType="pmc">PMC5217320</ArticleId><ArticleId IdType="pubmed">28056984</ArticleId></ArticleIdList></Reference><Reference><Citation>Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, et al. . Increased expression of inflammatory mediators in small-airway epithelium from tobacco smokers. Am J Physiol Lung Cell Mol Physiol. (2000) 278:L906–13. doi: 10.1152/ajplung.2000.278.5.L906</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.2000.278.5.L906</ArticleId><ArticleId IdType="pubmed">10781420</ArticleId></ArticleIdList></Reference><Reference><Citation>Waltl EE, Selb R, Eckl-Dorna J, Mueller CA, Cabauatan CR, Eiwegger T, et al. . Betamethasone prevents human rhinovirus- and cigarette smoke- induced loss of respiratory epithelial barrier function. Sci Rep. (2018) 8:9688. doi: 10.1038/s41598-018-27022-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-27022-y</ArticleId><ArticleId IdType="pmc">PMC6018698</ArticleId><ArticleId IdType="pubmed">29946071</ArticleId></ArticleIdList></Reference><Reference><Citation>Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodríguez-Tenreiro C, Sly P, Ramilo O, et al. . Respiratory syncytial virus seasonality: A global overview. J Infect Dis. (2018) 217:1356–64. doi: 10.1093/infdis/jiy056</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy056</ArticleId><ArticleId IdType="pubmed">29390105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee WM, Lemanske RF, Evans MD, Vang F, Pappas T, Gangnon R, et al. . Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med. (2012) 186:886–91. doi: 10.1164/rccm.201202-0330OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201202-0330OC</ArticleId><ArticleId IdType="pmc">PMC3530215</ArticleId><ArticleId IdType="pubmed">22923659</ArticleId></ArticleIdList></Reference><Reference><Citation>Andeweg SP, Schepp RM, Van De Kassteele J, Mollema L, Berbers GAM, Van Boven M. Population-based serology reveals risk factors for RSV infection in children younger than 5 years. Sci Rep. (2021) 11:8953. doi: 10.1038/s41598-021-88524-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88524-w</ArticleId><ArticleId IdType="pmc">PMC8076290</ArticleId><ArticleId IdType="pubmed">33903695</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker RE, Mahmud AS, Wagner CE, Yang W, Pitzer VE, Viboud C, et al. . Epidemic dynamics of respiratory syncytial virus in current and future climates. Nat Commun. (2019) 10:5512. doi: 10.1038/s41467-019-13562-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13562-y</ArticleId><ArticleId IdType="pmc">PMC6892805</ArticleId><ArticleId IdType="pubmed">31797866</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Prel J, Puppe W, Gröndahl B, Knuf M, Weigl JAI, Schaaff F, et al. . Are meteorological parameters associated with acute respiratory tract infections? Clin Infect Dis. (2009) 49:861–8. doi: 10.1086/605435</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605435</ArticleId><ArticleId IdType="pubmed">19663691</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsen MG, Christiansen LE, Græsbøll K. Seasonal variation in the transmission rate of covid-19 in a temperate climate can be implemented in epidemic population models by using daily average temperature as a proxy for seasonal changes in transmission rate. Microb Risk Anal. (2022) 22:100235. doi: 10.1016/j.mran.2022.100235</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mran.2022.100235</ArticleId><ArticleId IdType="pmc">PMC9546506</ArticleId><ArticleId IdType="pubmed">36248679</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang JW, Loh TP. Correlations between climate factors and incidence-a contributor to RSV seasonality: Climate factors and RSV infections. Rev Med Virol. (2014) 24:15–34. doi: 10.1002/rmv.1771</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1771</ArticleId><ArticleId IdType="pubmed">24421259</ArticleId></ArticleIdList></Reference><Reference><Citation>Megremis S, Niespodziana K, Cabauatan C, Xepapadaki P, Kowalski ML, Jartti T, et al. . Rhinovirus species–specific antibodies differentially reflect clinical outcomes in health and asthma. Am J Respir Crit Care Med. (2018) 198:1490–9. doi: 10.1164/rccm.201803-0575OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201803-0575OC</ArticleId><ArticleId IdType="pmc">PMC7212800</ArticleId><ArticleId IdType="pubmed">30134114</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraz AS, Belo EF, Coutinho LM, Oliveira AP, Carmo AM, Franco DL, et al. . Storage and stability of IgG and IgM monoclonal antibodies dried on filter paper and utility in Neisseria meningitidis serotyping by Dot-blot ELISA. BMC Infect Dis. (2008) 8:30. doi: 10.1186/1471-2334-8-30</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-8-30</ArticleId><ArticleId IdType="pmc">PMC2311311</ArticleId><ArticleId IdType="pubmed">18325118</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith GJ, Morris TT, Tudball MJ, Herbert A, Mancano G, Pike L, et al. . Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. (2020) 11:5749. doi: 10.1038/s41467-020-19478-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19478-2</ArticleId><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>